肺癌分子诊断及其研究进展

Molecular diagnostics of lung cancer and its research progress

分子标记物是恶性肿瘤研究领域的研究热点,对肿瘤的早期诊断、预后监测及治疗具有至关重要的临床意义。通过分子诊断指导患者个体化的精准治疗,已逐渐成为肿瘤临床治疗的共识。文章就分子诊断技术在肺癌中的研究进展进行介绍。

Molecular markers are research hotspot in the field of malignant tumor research, and have important clinical significance for early diagnosis, prognosis monitoring and treatment of tumors. The precise treatment of individualized patients through molecular diagnosis has gradually become the consensus of clinical treatment of tumors. This article introduces the research progress of molecular diagnostic techniques in lung cancer.